chr11-118436566-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001197104.2(KMT2A):c.54C>T(p.Gly18Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000446 in 1,166,660 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00023 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000018 ( 0 hom. )
Consequence
KMT2A
NM_001197104.2 synonymous
NM_001197104.2 synonymous
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 1.26
Publications
0 publications found
Genes affected
KMT2A (HGNC:7132): (lysine methyltransferase 2A) This gene encodes a transcriptional coactivator that plays an essential role in regulating gene expression during early development and hematopoiesis. The encoded protein contains multiple conserved functional domains. One of these domains, the SET domain, is responsible for its histone H3 lysine 4 (H3K4) methyltransferase activity which mediates chromatin modifications associated with epigenetic transcriptional activation. This protein is processed by the enzyme Taspase 1 into two fragments, MLL-C and MLL-N. These fragments reassociate and further assemble into different multiprotein complexes that regulate the transcription of specific target genes, including many of the HOX genes. Multiple chromosomal translocations involving this gene are the cause of certain acute lymphoid leukemias and acute myeloid leukemias. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2010]
KMT2A Gene-Disease associations (from GenCC):
- Wiedemann-Steiner syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Illumina, Labcorp Genetics (formerly Invitae), ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 11-118436566-C-T is Benign according to our data. Variant chr11-118436566-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 754854.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.26 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000225 (34/150794) while in subpopulation AMR AF = 0.00204 (31/15180). AF 95% confidence interval is 0.00148. There are 0 homozygotes in GnomAd4. There are 19 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 34 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KMT2A | ENST00000534358.8 | c.54C>T | p.Gly18Gly | synonymous_variant | Exon 1 of 36 | 1 | NM_001197104.2 | ENSP00000436786.2 | ||
ENSG00000285827 | ENST00000648261.1 | c.-798-32209C>T | intron_variant | Intron 1 of 6 | ENSP00000498126.1 |
Frequencies
GnomAD3 genomes AF: 0.000226 AC: 34AN: 150686Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
34
AN:
150686
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000177 AC: 18AN: 1015866Hom.: 0 Cov.: 20 AF XY: 0.0000146 AC XY: 7AN XY: 480278 show subpopulations
GnomAD4 exome
AF:
AC:
18
AN:
1015866
Hom.:
Cov.:
20
AF XY:
AC XY:
7
AN XY:
480278
show subpopulations
African (AFR)
AF:
AC:
0
AN:
21210
American (AMR)
AF:
AC:
7
AN:
7320
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
12112
East Asian (EAS)
AF:
AC:
0
AN:
23382
South Asian (SAS)
AF:
AC:
1
AN:
19048
European-Finnish (FIN)
AF:
AC:
0
AN:
28638
Middle Eastern (MID)
AF:
AC:
0
AN:
3152
European-Non Finnish (NFE)
AF:
AC:
0
AN:
861620
Other (OTH)
AF:
AC:
10
AN:
39384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.536
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000225 AC: 34AN: 150794Hom.: 0 Cov.: 32 AF XY: 0.000258 AC XY: 19AN XY: 73678 show subpopulations
GnomAD4 genome
AF:
AC:
34
AN:
150794
Hom.:
Cov.:
32
AF XY:
AC XY:
19
AN XY:
73678
show subpopulations
African (AFR)
AF:
AC:
2
AN:
41340
American (AMR)
AF:
AC:
31
AN:
15180
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3460
East Asian (EAS)
AF:
AC:
0
AN:
5120
South Asian (SAS)
AF:
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
AC:
0
AN:
10018
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
0
AN:
67554
Other (OTH)
AF:
AC:
1
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Dec 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jun 16, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Uncertain
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.